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http://dx.doi.org/10.1016/j.jfma.201Patients with asthma may also have vocal cord dysfunction (VCD), which leads to poor control
of the asthma. Once patients are diagnosed with difficult-to-treat asthma with poor control,
VCD should be excluded or treated accordingly. The gold standard for diagnosis of VCD is to
perform a laryngoscopy. However, this procedure is invasive and may not be suitable for pa-
tients with difficult-to-treat asthma. Four-dimensional (4D) dynamic volume computed tomog-
raphy (CT) is a noninvasive method for quantification of laryngeal movement, and can serve as
an alternative for the diagnosis of VCD. Herein, we present a series of five cases with difficult-
to-treat asthma patients who were diagnosed with VCD by 4D dynamic volume CT. Clinicians
should be alert to the possibility of VCD when poor control is noted in patients with asthma.
Early diagnosis by noninvasive 4D dynamic volume CT can decrease excessive doses of inhaled
corticosteroids.
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Asthma is defined as a chronic inflammatory disease of the
airways, and the symptoms can usually be relieved with
inhaled corticosteroids.1 However, in 5e10% of asthma
patients the symptoms may continue to deteriorate even
with high-dose inhaled and oral corticosteroid treatment.2
The patients with difficult-to-treat asthma may require
repeated hospital admissions, which results in increased
health-care costs and the patient’s work performance being
affected.3 Thus, it is necessary to investigate the etiolog-
ical factors for the difficulties experienced by the patients
with severe asthma while treating them. Once the under-
lying causes of these difficulties are known, treatment can
be adjusted accordingly and excessive medication can be
reduced, especially inhaled corticosteroids.
Vocal cord dysfunction (VCD), also known as paradoxical
vocal cord motion, is a common etiology leading to diffi-
culty in treating asthma patients.4,5 Because of involuntary
closure of the vocal cords, which occurs most commonly
during inspiration, VCD can masquerade the symptoms of
asthma such as episodic and severe respiratory distress.6
The diagnosis of VCD is traditionally based on a combina-
tion of inspiratory flow volume loops and laryngoscopy
during symptom attack. However, recent studies have re-
ported that four-dimensional (4D) dynamic computed to-
mography (CT) is a noninvasive method for the
quantification of laryngeal movement, and can serve as an
alternative for the diagnosis of VCD.5,7 In recent years, CT
has progressed from 64 slice to 320 slice, thereby providing
far more detailed images of structures, making it possible
to model the airflow in the respiratory system and provide
more accurate imaging of laryngeal function during the
phases of respiration. Therefore, 320-slice CT has the po-
tential to become the new standard for VCD diagnosis. One
study used 320-slice CT to survey upper airway dysfunction
in a patient who had severe asthma,7 and another study
defined the normal parameters for laryngeal movement in
the context of this new imaging modality.5
In the case series in this study, we used 4D dynamic
volume CT to survey patients with difficult-to-treat asthma.
A retrospective analysis has been performed in these pa-
tients. A 4D dynamic volume CT (Toshiba Aquilion ONE, 320-
slice CT system) was performed with the following param-
eters: 80 kVp, 50 mAs, detector collimation, 0.5  0.5 mm2;
gantry rotation, 0.5 seconds; scanning time, 10 seconds;
scanning range, 16 cm; reconstructed slice thickness/in-
terval, 3 mm/3 mm. The radiation dose of 4D CT was in a
range of approximately 3e5 mSv. The CT protocol and
respiratory instructions were fully explained and given to
all patients by the same radiographer. All patients were
requested to breathe normally to determine their own
respiratory tempo lasting for 10 seconds without a breath
hold and swallowing, during the preprocedure respiratory
practice and 4D-CT study.
Dynamic sagittal and coronal multiplanar images and
dynamic 3D volume rendering images from approximately
the hyoid level to the distal trachea including vocal cords
were reconstructed using Toshiba Aquilion ONE Manufac-
turer’s Model version V4.74ER011. We selected the mid-
phase inspiration and expiration to take a steady vocal cord
4D dynamic volume CT for vocal cord dysfunction 1287luminal area and get average value, respectively, if more
than one inspiration or expiration phase was recorded. We
presented five patients (Table 1) who fit the VCD diagnostic
criteria (vocal cord area >40% reduction and sustained
>70% cycle) (Table 2) in 4D dynamic volume CT.7
Case series
Case 1
This 52-year-oldmale had asthma since the age of 10 andwas
prone to anxiousness. He had underlying hypertension and
had suffered from an ischemic stroke when he was 50 years
old. Frequent night and morning coughing were noted. His
asthma symptoms and signs exacerbated when he caught a
cold or suffered an allergic reaction. To better control his
asthma symptoms, a leukotriene receptor inhibitor and
theophylline were added along with a b2 agonist and inhaled
corticosteroids. However, he still often complained of neck
tightness and shortness of breath, and he frequently visited
the emergency room due to dyspnea. Because of persistent
progressive shortness of breath and chest tightness, he was
suspected as having difficult-to-treat asthma. The 4D dy-
namic CT was performed. Subsequently, VCD was initially
suspected. In addition to inhaled combination therapy and
anticholinergics, he also received speech therapy, breathing
control, and psychological support. Subjective symptomatic
improvement of upper airway discomfort was noted. No
emergency roomor unscheduled outpatient clinic visitswere
noted, after such management for 3 months.
Case 2
A 65-year-old female patient had been diagnosed with
asthma at 27 years of age. She also had underlying chronic
rhinitis, postnasal drip, and hypertension. Frequent upper
airway discomfort and a sensation of suffocation were
noted despite the use of inhaled combination therapy. Her
immunoglobulin E (IgE) level was 92.1 KU/L and she had
received omalizumab therapy. Her symptoms improved
after anti-IgE therapy; however, chest tightness and
frequent upper airway infections still occurred. The 4D
dynamic volume CT was performed and VCD was initially
impressed. Thus, nonpharmacologic management,
including speech therapy, breathing control, and psycho-
logical support were arranged. After 2 months, obviousTable 2 Vocal cord luminal area in the study patients.
Patients Trachea luminal
area (mm2)
Maximal vocal
cord/trachea
luminal area (%)
Vocal cord lumina
during midphase
inspiration (mm2)
1 349.5 95% 332.6
2 269.6 28% 17.1
3 262.9 76% 41.9
4 271.4 72% 113.2
5 396.2 59% 40
Selected trachea level: cervicothoracic junction just below the thyro
*Expiration phase.symptomatic improvement of upper airway discomfort and
a sensation of suffocation were noted. Besides, the un-
scheduled outpatient clinic visit was decreased.
Case 3
This 64-year-old male patient had been diagnosed with
asthma at 62 years of age. He coughed more frequently
after exercise or during changes in the weather. Nocturnal
coughing was also noticed. He frequently suffered from
persistent dyspnea and intermittent chest tightness despite
receiving inhaled combination therapy. Under the impres-
sion of difficult-to-treat asthma, 4D 320-slice dynamic vol-
ume CT was arranged, which revealed paradoxical
inspiratory vocal cord luminal area reduction that was
diagnosed as VCD (Fig. 1). Symptomatic improvement of
VCD was noted after speech therapy, breathing control, and
psychological support for 1 month. No unscheduled outpa-
tient clinic visit was noted and we downstaged the asthma
severity thereafter.
Case 4
This 49-year-old male had a history of asthma and frequent
dyspnea since he was 20 years of age. He had also been a
heavy drinker and smoker in the past. Because of asthma
attacks with chest tightness at 45 years of age, he began
regular treatment with medications. He had previously
suffered from a near-fatal asthma attack with acute res-
piratory failure, and thus an emergency intubation with
mechanical ventilator support was performed. To control
the asthma symptoms, a leukotriene receptor inhibitor and
theophylline were added along with a b2 agonist and
inhaled corticosteroids. He had also received anti-IgE
therapy, which seemed to provide a good response. How-
ever, he still often complained of shortness of breath and
paroxysmal nocturnal dyspnea. Under the impression of
difficult-to-treat asthma, 4D dynamic volume CT was ar-
ranged and VCD was initially impressed. Thus, non-
pharmacologic management, including speech therapy,
breathing control, and psychological support were ar-
ranged. After 3 months, subjective symptomatic improve-
ment of upper airway discomfort was noted. No more
emergency room or unscheduled outpatient clinic visits
were noted after such management for 3 months. The doses
of anti-IgE therapy were also decreased thereafter.l area Vocal cord luminal
area during midphase
expiration (mm2)
Vocal cord luminal
area reduction during
inspiration or expiration* (%)
89.2 73%*
75.9 77%
202 79%
195.4 42%
232.4 83%
id level; scan at the end of deep inspiration.
Figure 1 (A) Nonenhanced axial computed tomography images of Case 3 showing normal lumen at the vocal cord level during
expiration and (B) paradoxical adduction of the vocal cords during inspiration that reduced the lumen by 79.3%, consistent with
vocal cord dysfunction. A small area at the posterior part of the airway was not affected (B, arrow). Volume rendering recon-
struction techniques show coronal images during (C) expiration and (D) inspiration, and sagittal images during (E) expiration and (F)
inspiration, demonstrating marked luminal narrowing with a posterior chink at the vocal cord level during inspiration (F, arrow).
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This 81-year-old male patient had a history of chronic
asthma for 10 years. A frequent sensation of a lump with
choking was noted. He had an underlying gastroesophageal
reflex disease, renal insufficiency, diabetes mellitus type II,
and hypertension with irregular control. His symptoms
included chest tightness and coughing with sputum. To
control the asthma symptoms, a leukotriene receptor
antagonist was added with a b2 agonist and inhaled corti-
costeroids. After a long period of outpatient department
follow-up but poor improvement of his symptoms, he was
considered to have difficult-to-treat asthma. Under the
impression of difficult-to-treat asthma, we arranged a 4D
dynamic CT for survey of VCD, and VCD was initially sus-
pected. Thus, nonpharmacologic management, including
speech therapy, breathing control, and psychological sup-
port were arranged. After 2 months, subjective symptom-
atic improvement of sensation of a lump with choking was
noted. Besides, there was no unscheduled visit to the
outpatient clinic.Discussion
In our case series, we used a 4D dynamic CT to diagnose
VCD. This technique made it possible to record the upper
airway movements of suspected VCD patients during the
respiratory cycle, and measure the area of the vocal cord
luminal area. VCD is defined as reductions in vocal cord
luminal area of >40% lasting for >70% duration of inspira-
tion or expiration.7 This definition is consistent with pa-
tients who abnormally adduct during inspiration or
exceedingly adduct during expiration. We recorded the
data from our five patients who underwent 4D dynamic CT
including vocal cord luminal area during midphase inspira-
tion (mm2), vocal cord luminal area during midphase expi-
ration (mm2), and vocal cord luminal area reduction during
inspiration or expiration (%) (Table 2). The most important
factor was the reduction in percentage of the vocal cord
luminal area during inspiration or expiration. From this, the
degree of vocal cord luminal area narrowing during the
respiratory cycle could be obtained. The reductions in vocal
cord luminal area ranged from 42% to 83%, which all
matched the imaging criteria of VCD diagnosis (reductions
in vocal cord luminal area > 40%).7 One of our patients with
VCD manifested this abnormality in expiration, and four in
inspiration. The VCD during expiration may mimic the
expiratory wheeze of asthma, and therefore, may be more
difficult to differentiate clinically.
Difficult-to-treat asthma refers to a patient with asthma
who has persistent asthma symptoms and exacerbations
despite high-dose asthma therapy. There is no universally
accepted definite definition of difficult-to-treat asthma;
however, recent work has suggested that the term “diffi-
cult-to-treat asthma” can be used when a treatment level
reaches at least Step 4 of the British Thoracic Society
guidelines (high-dose inhaled corticosteroid and long-acting
b2 agonist treatment).8 It has been reported that 5e10% of
asthma patients suffer from difficult-to-treat asthma.9
Once a patient with difficult-to-treat asthma is encoun-
tered, clinicians must reconsider whether or not thediagnosis is correct, and whether there are potential
coexisting problems contributing to the asthma exacerba-
tion. If coexisting conditions can be identified and
managed, better symptom control may be possible. Clini-
cians should consider potential problems that accompany
or mimic asthma including bronchiectasis, gastroesopha-
geal reflex disease, rhinosinusitis, psychological disorders,
and VCD. Among these, VCD is one of the most difficult to
differentiate from asthma by clinical symptoms such as
wheezing, breathlessness, and triggering through exercise.
The prevalence of VCD is uncertain, and the diagnosis
requires a high index of suspicion and direct visualization of
the vocal cords by laryngoscopic demonstration when
symptomatic.10 The golden standard to diagnose VCD is to
use endoscopy to visualize the exact movement of the vocal
cords. However, the accuracy is limited by the subjectivity
of the clinician. By contrast, 4D dynamic CT provides an
objective, noninvasive, alternative diagnostic tool for VCD
diagnosis. In addition, it is simple and makes it easier to
detect the laryngeal function in those who are suspected of
having VCD. The crucial consideration regarding our case
series is whether excessive narrowing of the vocal cords as
demonstrated by CT may be an error in the interpretation
of the CT images or alternatively, a physiological phenom-
enon. Thus, when this technique is used to make a diag-
nosis, clinicians have to consider whether the excessive
narrowing we detected is the natural state or an error of CT
image interpretation.
The primary treatment for VCD is laryngeal control
therapy, which is typically provided by speech language
pathologists and is a noninvasive treatment that has shown
modest improvement in VCD.11 Some patients benefit from
speech therapy, which can emphasize breathing through
the abdomen as opposed to thoracic breathing. A previous
study found that 95% of female athletes treated with
speech therapy were able to adequately control their
symptoms.12 However, whether it has an impact on asthma
control has not yet been established. Other proposed
therapies are psychotherapy, biofeedback, and inhaled
anticholinergic medications.13 It is also crucial to control
the accompanying irritating factors such as allergic rhinitis
with postnasal drip and gastroesophageal reflux. Patients
with psychological or psychiatric illnesses may not be able
to overcome VCD. When this is the case, it is important to
avoid continued treatment with systemic corticosteroids
unless it is demonstrated that there is both persistent
asthma and VCD.14
Conclusion
A high index of suspicion is required to diagnose VCD.15
Clinicians should consider VCD in any patient with a his-
tory of asthma and continued symptoms despite treatment.
Early diagnosis by noninvasive 4D dynamic volume CT can
decrease excessive doses of inhaled corticosteroids.
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